comscore Hawaii Biotech exits bankruptcy
Top News

Hawaii Biotech exits bankruptcy

Honolulu Star-Advertiser logo
Unlimited access to premium stories for as low as $12.95 /mo.
Get It Now

Hawaii Biotech Inc. has emerged from Chapter 11 bankruptcy nearly a year after it sold its dengue fever vaccine research unit to pharmaceutical giant Merck & Co. 

The privately-held biotech company, which develops vaccines for infectious diseases, filed for Chapter 11 reorganization in December 2009 after a shareholder dispute blocked venture capital financing.

U.S. Bankruptcy Judge Robert Faris confirmed today the company’s reorganization plan and the close of bankruptcy proceedings.

Comments have been disabled for this story...

Click here to see our full coverage of the coronavirus outbreak. Submit your coronavirus news tip.

Be the first to know
Get web push notifications from Star-Advertiser when the next breaking story happens — it's FREE! You just need a supported web browser.
Subscribe for this feature

Scroll Up